Development of novel compounds as Chemotherapeutic Drugs Targeting the MDM2-p53 Interaction
Molbiyokon’18, Biomedicine and Genome Center, İzmir, Turkey, 5 - 08 September 2018, pp.62, (Full Text)
- Publication Type: Conference Paper / Full Text
- City: İzmir
- Country: Turkey
- Page Numbers: pp.62
- Istanbul University Affiliated: Yes